ASP4132
规格
| Cas Number | 1640294-30-9 |
| 规格或纯度 | ≥98% |
| 纯度 | ≥98% |
| 包装 | 5mg 或 25mg |
产品信息
| 品牌 | 阿拉丁 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 100 mg/mL (106.71 mM); Water: Insoluble; Ethanol: Insoluble; |
| 简短描述 | AMPK 活化剂 |
| 英文简短描述 | AMPK Activators |
| 过滤标签 | 表观遗传学,AMPK,PI3K/Akt/mTOR |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 生化和生理学机理 | ASP4132 是一种强效的单磷酸腺苷激活蛋白激酶（AMPK）口服活性激活剂，EC50 为 0.018 μM。ASP4132 是治疗人类癌症的临床候选药物。 |
| 描述 |
ASP4132 是一种具有口服活性，有效的 AMPK 激活剂，EC50 为 18 nM。ASP4132 具有抗癌活性，可在乳腺癌异种移植小鼠模型中促使肿瘤消退。 |
| 英文描述 |
Information ASP4132 ASP4132 is a potent and orally active activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) with EC50 of 0.018 μM. ASP4132 is used as a clinical candidate for the treatment of human cancer. Targets AMPK (Cell-free assay) 0.018 μM(EC50) In vitro ASP4132 is a new type of AMPK activator with potent AMPK activation activity and attractive selective growth inhibition against human cancer cells, improves aqueous solubility, metabolic stability and animal pharmacokinetics (PK). Studies on ASP4132 have advanced to clinical trials for the treatment of cancer. In vivo The in vivo efficacy of ASP4132 is evaluated via MDA-MB-453 xenografts in nude mice. The tumor growth inhibition (TGI) rate is 29% at 1 mg/kg (p.o.), and the tumor regression rate is 26%, 87% and 96% at 2, 4 and 8 mg/kg, respectively. All doses of ASP4132 are well tolerated over the 21-day dosing window, and no body weight loss is observed. Cell Research(from reference) Cell lines：MDA-MB-453, SK-BR-3, AU565, OCUB-M, Concentrations：0.3 nM, 1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1000 nM, 3000 Nm Incubation Time：2 h, 4 days |